The dose-related effects of the fiber-rich isolate, soft white wheat bran (SWWB), and the pure fiber, cellulose, on Nnitrosomethylurea (NMU)-induced mammary tumorigenesis was assessed in F344 female rats. SWWB (45% total dietary fiber, TDF) was added to the AEN-76A high-fat diet at 9, 12, 15 and 18%; cellulose (98% TDF) was added to the same diet at 4.5, 6, 7.5 and 9%, to give equivalent amounts of TDF. The experimental diets were fed 3 days post-NMU and continued for a period of 25 weeks, at which time the experiment was terminated and tumors enumerated. It was found that significant inhibition of mammary carcinoma occurred only at 9% SWWB, nonsignificant inhibition occurred at 12% SWWB, and no inhibition was seen at higher doses. Cellulose-fed animals exhibited consistently higher tumor yields regardless of dose. The difference in tumor yields between the 9% SWWB group and the remaining seven groups was attributable to an increased incidence in tumors characterized histologically as intraductal proliferation and ductal carcinoma in situ in the latter. Analysis of blood, urine and fecal estrogens was conducted to test whether dietary fiber exerted its tumor-inhibiting effect by altering the enterohepatic recycling of estrogens. Although SWWB, in general, lowered urinary estrogen excretion, increased fecal estrogen excretion and lowered blood estrogens, there was no consistent correlation between the amount of SWWB consumed, estrogen status and tumor yields. These results suggest that (i) wheat bran fiber at 9%, or minor constituents associated with it, contain anti-promoting properties that cellulose lacks; (ii) SWWB appears to exert its effects by suppressing the clonal expansion phase of mammary carcinogenesis; (iii) there is an upper limit (12-15% w/w) to the protective effects of SWWB; and (iv) the effects of SWWB on mammary tumorigenesis may not be attributed to alterations in the enterohepatic recycling of estrogens.
Introduction
Epidemiologic evidence provides support, with some exceptions (1,2), for the hypothesis that dietary fiber, or compounds of plant origin associated with dietary fiber, may be protective against breast cancer (3) (4) (5) (6) (7) (8) . Moreover, recent studies by Cohen et al. (9, 10) and Arts et at. (11) have directly demonstrated that supplemental wheat bran suppressed the development of chemically induced rat mammary tumors. Several mechanisms have been proposed by which dietary fiber may exert its
•Abbreviations: E|S, estrone-3-sulfate; SWWB, soft white wheat bran; NMU, A'-nitrosomethylurea; TDF, total dietary fiber, E,, estrone; Ej, l7pVestradiol; Ej, estriol; DCIS, ductal carcinoma in situ; IDP, intraductal proliferation.
protective effects (12) . Primary among these is the concept that fiber exerts its effects by altering the enterohepatic recirculation of estrogens, resulting in decreased exposure of the mammary gland to estrogens (13) . Several studies have shown that women consuming high levels of fiber exhibit (i) decreased urinary excretion of conjugated estrogens, (ii) enhanced fecal elimination of unconjugated estrogens (14) (15) (16) , and (iii) decreased serum estrogens including estrone-3-sulfate (E]S*), the principal circulating form of estrogen. Based on these and other findings, it has been proposed (13) that the observed alterations in estrogen disposition were a consequence of the growth-suppressing effect of fiber in deconjugating (P-glucuronidase and sulfatase-producing) colonic bacteria. Hence, by suppressing hydrolysis of biliary estrogen conjugates by colon flora-a step necessary for reabsorption of 80% of total colonic estrogens into the circulation-high fiber intake was envisioned to decrease the availability of estrogens necessary for continued tumor growth and development.
Based largely on epidemiological studies linking low fiber intake with colon cancer risk, several governmental agencies have proposed that dietary fiber intake, currently 10-12 g/ 2000 cal, should be increased to 25 g or more, from a broad variety of food sources for normal bowel health and for optimal protection against cancer (17) (18) (19) (20) (21) (22) . However, as of the present time, there are no quantitative experimental data supporting the proposed fiber guidelines with regard to breast cancer risk reduction. In the present study, therefore, we have assessed the dose-related effects of a fiber-rich isolate, soft white wheat bran (SWWB), and a purified fiber cellulose, on Nnitrosomethylurea (NMU)-induced mammary tumor development. Based on the premise that SWWB contains specific antipromoting properties, not present in pure cellulose (9) (10) (11) , our expectation was that tumor yields would decrease monotonically as SWWB levels increased, whereas increasing amounts of pure cellulose would have no effect on tumor yields. In addition, we have tested the hypothesis that these dietary factors exert their biological effects by both qualitatively and quantitatively altering the enterohepatic recirculation of estrogens.
Materials and methods

Experimental tumor induction protocol
Two-hundred-and-forty virgin female inbred F344 rats, 28 days of age (Charles River Breeding Laboratories, North Wilmington, MA), were maintained on the standard NIH-07 diet (Zeigler Bros, Gardners, PA) (23) until 50 days of age. All rats were then assigned to eight groups of 30 each by recognized randomization procedures (24) to equalize initial weight On day 50 of age, all rats received a single dose (40 mg/kg body wt) of NMU (CAS 684-93-5; Ash Stevens Inc., Detroit, MI) by tail vein injection. NMU was dissolved in a few drops of 3% acetic acid and diluted with distilled water to give a stock solution of 10 mg NMU/ml, which was administered within 2 h of preparation (25) .
Diet administration
Three days after NMU administration, the rats were transferred to one of eight different experimental diets (Table I) . The diets were formulated in our diet kitchen based on a modification of the AIN-76A diet (26) . All ingredients 
Diets
Diets were prepared in 15 kg lots in our kitchen and were stored at 4°C until used. The diets were formulated to account for the carbohydrate, protein and fat contributed by the SWWB. The diets provided -18 cal/day as fat (40% of total calories). Rats were fed three times per week, and feeders were removed and washed after each feeding.
Animals
Animals received proper care and maintenance in accordance with institutional guidelines. Three rats were housed in a polyethylene cage that contained hardwood shavings and was covered with a filter top. The animal room was controlled for temperature (24±2°C), light (12 h cycle) and humidity (50%). Diets were provided in powdered form, and tap water was provided ad libitum. Stainless steel 'J'-type powder feeders were used to prevent scattering of food.
Observation schedule
At weekly intervals, beginning 4 weeks after NMU injection, each rat was weighed, and the location and date of palpable tumor(s) were recorded.
Urine and feces collection
Approximately 22 weeks post-NMU, six animals from each group were placed in metabolism cages and 24 h urine and fecal collections were conducted. Urine (10-15 ml/24 h) was collected on dry-ice in 50 ml conical centrifuge tubes, centrifuged at 200 g and the clear supernatant stored at -20°C until use. Fecal pellets were collected, placed in tightly capped 20 ml scintillation vials and stored at -20°C until analyzed.
Necropsy, serum and cecal collection, histopathology
Approximately 25 weeks after NMU administration, the experiment was terminated. Blood was drawn from the rats by heart puncture under ketamine anesthesia between 11 a.m. and 1 p.m. in order to minimize variation in hormone levels (27) , and collected in evacuated, sterile Autosep tubes (Terumo Med., Elkton, MD). Serum and red blood cells were then separated by centrifugation. Serum was stored at -20°C until it was assayed. Blood was taken during metestrus, diestrus and late estrus (not proestrus). Rats were then killed by carbon dioxide inhalation, and mammary tumors, classified as palpable or non-palpable but grossly visible, were excised, fixed in 10% buffered formalin, blocked in paraffin, and stained with H&E for histologic examination. Histologic diagnosis of mammary tumors was based on criteria outlined by Young and Hallowes (28) and Russo et al. (29) .
Statistical analysis
Tumor-free survival was estimated separately for each experimental group by the Kaplan-Meier product limit life-table method (30) . The survival distributions for the different dietary groups were then compared by the logrank test (31, 32) . The purpose of this method was to test the null hypothesis that all eight survival functions were identical. Differences in total tumors per group were assessed by the chi-square test of association. Differences in the overall frequency of tumors per rat (including tumor-free rats) and in the number of tumors per tumor-bearing rat were assessed by Armitage's test for trends in proportions (33) . Weight gain over time was compared by factorial analysis of variance with repeated measurement (34) .
Serum estrogen assay
The method for conjugated and unconjugated serum estrogen assay was a modification of that published by Adlercreutz et al. (35) . To 1 ml of serum were added 2.3 ml 100% methanol to precipitate out protein, remove lipid and free unconjugated estrogens from their binding proteins. The mixture was placed at 4°C for 20 min and then centrifuged at 2300 g for 10 min and the supernatant saved. One milliliter of 70% methanol was then added to the supernatant and the mixture treated as above. The two supematants were then combined and dried under nitrogen. Distilled H2O (2 ml) was then added to the residue and the mixture extracted with 2 X 5.0 ml diethyl ether. The ether layer, containing unconjugated estrogens (extraction efficiency >95%), was then blown dry under nitrogen and the residue brought up in buffer and assayed by radioimmunoassay (RIA) using a kit purchased from Wein Laboratories Inc. (Succasunna, NJ). The aqueous layer containing estrogen sulfate was placed under a stream of nitrogen gas for 30 min to remove residual ether. Arylsulfatase solution (0.25 ml, 250 U) (Sigma Chemical, St Louis, MO; type H-l from Helix pomatia) pretreated with activated, neutralized charcoal (Sigma), in a sodium acetate buffer (pH 4.2), was then added and the reaction mixture incubated in a shaker bath overnight at 37°C. The crude snail enzyme preparation was purified prior to use by treatment with activated charcoal as follows: 200 mg of charcoal were added to 1 ml of the enzyme preparation (2500 U/ml). The suspension was then agitated with a magnetic stirrer for 2 h at room temperature and centrifuged at 18 900 g for 30 min. The supernatant was filtered through Celite prior to use. Following enzymatic hydrolysis, the mixture was extracted with 2 X 5.0 ml diethylether to obtain free estrone (E|). The ether phase was then dried under nitrogen gas and the residue assayed by RIA for E| using the Wein Laboratories kit. The E| assay is highly specific [cross-reactivity with 17(i-estradiol (E 2 ) and estriol (E 3 ) <0.025] and sensitive (10 pg/ml detectable). Radioactive aliquots were counted in an LKB (Wallac Inc., Gaithersburg, MD) liquid scintillation counter, and RIA data processed using a computer program obtained from Robert Maciel Associates Inc. (Arlington, MA). Based on radiometric measurement using [ 3 HJE|S ammonium salt (54 Ci/mmol) (New England Nuclear, E.I.Dupont Nemours, Wilmington, DE), the efficiency of estrone sulfate recovery from rat serum was 70%. Intra-assay variation (CV) was 3.0-7.5% and interassay variation (CV) was 8.8-16.5%. The data were expressed as pg/ml estrone sulfate (as E|) after adjustment for extraction efficiency.
Urinary estrogen analysis
The method used was a modification of that described by Adlercreutz et al. (35) . Urinary estrogens are present primarily as water-soluble conjugates. Hence a deconjugation step is required prior to assay by RIA. For E, and E 2 , 0.3 ml of unne was added to 0.7 ml H 2 O; for E3, 0.06 ml of urine was brought up to 1 ml with H 2 O. After vortexing for 20 s, 0.2 ml of fJ-r> glucuronidase (EC 3.2.1.31), type H-5 from H.pomalia (Sigma) was added to the urine sample. The reaction mixture, containing 2000 U glucuronidase activity/sample, was then vortexed and incubated overnight in a shaker bath at 37°C. The reaction mixture was then extracted with 2 X 5 ml diethylether.
The deconjugated estrogens present in the ether fraction were dried and the residue used for RIA of E|, E 2 and E3 using kits obtained from Wein Laboratories. The E 2 and E3 kits were highly specific (cross-reactivity with E| or E 2 , E 3 , <0.025%) and sensitive (10 pg/ml detectable). All extractions were done in duplicate. The data were expressed as pg estrogen/mg creatinine to account for variations in total 24 h urinary output.
Unconjugated fecal estrogen assay
The method used was based on that of Adlercreutz el al. (35, 36) . Approximately 70-80% of rat fecal estrogens are present in the unconjugated form (7). Fecal pellets were weighed (wet weight) and then freeze-dried. Following lyophilization, the pellets were weighed again (dry weight), ground to a powder with a mortar and pestle and 5 ml of 70% methanol were added to 0.25 g of powdered feces. The mixture was sonicated for 10 min, vortexed for 1 min and centrifuged at 3000 r.p.m. for 10 min. The clear supernatant was saved and the procedure repeated with the pellet. The two supernatants were then pooled and placed at -20°C overnight to precipitate lipids and protein.
The mixture was centrifuged and the methanol layer dried under nitrogen gas until ~2 ml remained. Estrogens were extracted with 2 X 5 ml ether after adding I ml acetate buffer, pH 4.2. The ether layer was then decanted and dried under nitrogen gas. The dried residue containing estrogens and interfering contaminants was further purified by ion exchange chromatography. The residue was brought up in 70% methanol and passed through a DEAE-Sephadex A-25 column (acetate form). The column was eluted with 1.0, 1.0 and 6.0 ml 70% methanol. The eluates were combined in a 16 X 100 mm glass tube and dried under nitrogen gas. The residue was dissolved in 1 ml ethanol, vortexed and 0.05 ml transferred to three different tubes for E|, E 2 and E3 assay. The tubes were dried down one more time and then assayed by RIA. The data were expressed as ng/g feces or ng/24 h fecal collection.
Results
Tumor yields
Addition of increasing levels of SWWB to a high-fat diet did not result in a monotonic decline in mammary tumor yields as expected. Instead, addition of SWWB at 9% (w/w) resulted in a statistically significant inhibition of total mammary tumorigenesis compared to all groups (except group 2, 12% SWWB), when assessed in terms of tumor incidence or total tumor number (Tables II and III) , tumor multiplicity (Table II) or latency (Figure 1) .
The histopathological profile of the mammary tumors induced by NMU included adenocarcinoma, ductal adenocarcinoma in situ (DCIS) and intraductal proliferation (IDP). The latter two appeared as adenomas with small clusters of malignant epithelial cells confined to the intraductal space. Also termed intraepithelial neoplasia, this class of tumors was found only in groups 2-8 (Table III) . In contrast to total palpable mammary tumors, when tumor yields were assessed in terms of adenocarcinoma alone, it can be seen that statistically significant differences between any of the eight groups could not be detected. Hence, the key difference between the 9% SWWB group and the other seven treatment groups was the presence of IDP and DCIS tumors in the latter and their absence in the former.
Overall, animal weight gains were similar in all groups with L.A.Cohen el at.
Life Table Analysis Of Total Tumor Incidence the exception of an increase detected in group 5 (4.5% alphacel) at 8 weeks post-NMU treatment (Figure 2) .
Serum estrogens
Single-point serum estrogen levels did not vary in any consistent way with either the amount of SWWB or alphacel in the diet or with tumor yields (Tables IV and V) . Collectively, animals fed SWWB exhibited non-significantly lower levels of E,S than those fed alphacel, and 18% SWWB exhibited significantly lower levels of E)S compared to its 9% alphacel counterpart. Mean levels of E 2 were the lowest in the 9% SWWB group but not significantly ( Table V) . The SWWBfed animals (groups 1-4) exhibited significantly decreased circulating E 2 levels when they were collectively compared with the four alphacel groups (groups 5-8). Although mean levels of E, were the lowest in the 9% SWWB group (Table V) , pairwise comparisons did not reach statistical significance. When compared collectively, the SWWB group exhibited decreased E, levels compared to the alphacel group, but this decrease was not statistically significant.
Urinary estrogens
Single-point 24 h urinary estrogens (E b E 2 , E 3 ) exhibited no consistent pattern with regard to the amount of dietary SWWB or alphacel intake, or with overall tumor yields (Table VI) . However, collectively, rats fed SWWB exhibited decreased urinary excretion of total estrogens compared to alphacel-fed rats (P < 0.0008). Mean urinary E, levels were also significantly decreased in the SWWB groups (1-4) compared to the alphacel groups (5-8) (P < 0.0016) collectively. Alphacel/ SWWB comparisons indicated significantly decreased mean urinary E, concentrations in the SWWB groups as follows: group 1 versus 6, group 2 versus 6 and group 4 versus 8, and with regard to mean estradiol concentrations, group 2 versus 6 and group 3 versus 7. As observed in earlier studies (9, 10, 15) , estrogens were present in the urine at concentrations -500-fold that of serum.
Fecal estrogens
Overall, the water content of the feces obtained from rats fed SWWB was significantly higher than that of rats fed alphacel (P < 0.01) (Table VII) . However, within the four SWWB groups or the four alphacel groups, there was no discernible dose-related pattern of water retention. The dry weights of the fecal pellets were similar in all groups (data not shown). When assessed in terms of ng estrogen excreted/24 h, there was a non-significant dose-related increase in fecal estrogen excretion patterns with increasing fiber intake in both the SWWB and alphacel groups, and an increase in E[ excretion when the pooled data from the SWWB groups were compared with the pooled data from the alphacel groups (data not shown). When assessed in terms of ng/g feces (Table VIII) , mean Ej levels were significantly increased in the four SWWB •Statistical analysis: mean total estrogens (E| + E2 + E 3 ) and estrone in combined SWWB groups (1-4) significantly less than in combined alphacel groups (5-8) (P < 0.0004) by Student's f-test. Mean total estrogens, group I versus group 5 (P < 0.049); group 2 versus 6 (P < 0.0002); group 4 versus group 8 (P < 0.0004); mean estrone, group 2 versus group 6 (P < 0.003); group 4 versus group 8 (P < 0.001); mean estradiol, group 2 versus group 6 (P < 0.024); group 3 versus group 7 (P < 0.01). All other pairwise comparisons, NS. Regression analysis for dose-related trends, NS. n =67group. •Statistical analysis: groups 1-4 significantly greater than groups 5-8 (P < 0.01). Pairwise comparisons: group 2 versus group 6 (P < 0.01). All pairwise comparisons, NS. Regression analysis for dose-related trends, NS. n = 6/group. 40% fat -> 25% fat 12 g fiber -» 40 g fiber/day for 8-10 weeks V = 24 g fiber/day NV = 13 g fiber/day 50 g fat V and NV wheat, com or oat bran 15 g fiber -> 30 g for 2 months <10% fat, 35-^0% fiber for 22 days V = 33% fat, 3.2 g fiber/day NV = 39% fat, 2.17 g fiber/day Vietnamese, 24%; Finnish, 42% fat fat intake 50 g/day fiber 10 g each serum E, I 15%, E 2 4 19% fecal E,, E 3 total E i urine E, 1, in vegetarians (follicular phase) serum E|S (follicular phase) i serum E2 4, E 2 S T in vegetarians serum E|, E 2 A wheat bran only plasm E 2 1 serum E 2 t in vegetarians (follicular phase) plasma E|S •!•, fecal total E T, urine E,, E 2 i (follicular phase) groups versus the alphacel groups (P < 0.0115) and mean E] levels in group 2 were significantly greater than group 6. However, within each fiber category, no significant trends in estrogen excretion were observed. As with urine, fecal estrogens were present in concentrations ~500-fold that of serum, a finding consistent with literature values (9, 10, 15) .
Discussion
This report shows that addition of SWWB to the AIN-76A high-fat diet at 9, 12, 15 and 18% (w/w) resulted in the suppression of mammary tumor development only at the lowest fiber dose (9% SWWB, 4.5% TDF); a slight suppression was seen at 12% SWWB (6% TDF) and no suppression was seen at 15% SWWB (7.5% TDF) or 18% SWWB (9% TDF).
Results from the four alphacel groups indicated no suppressive effect regardless of dose. These findings in the NMU-induced mammary tumor model suggest that SWWB possesses antipromoting agents not present in pure cellulose and that there is an upper limit to the protective effect of wheat bran. In addition, the results are inconsistent with a linear dose-response model for the anti-promoting effects of dietary fiber at amounts >12% w/w SWWB. It is of interest that the major effect of the 9% SWWB diet was to suppress the appearance of mammary tumors characterized by small intraductal nests of neoplastic cells or ductal carcinoma in situ. With respect to current theories of the natural history of breast cancer, in which carcinogenesis proceeds through a series of morphologically defined steps (37, 38) , this could be explained as a suppression of the clonal expansion of preneoplastic cells induced in ductal epithelium by exposure to the alkylating agent NMU. Accordingly, the fiber content of SWWB, or substances associated with it, can be conceived of as a concentration-dependent anti-promoting agent acting prior to or during the stage of clonal expansion.
Extrapolated to humans on a weight basis, 9% SWWB (4.5% TDF) in the rat is equivalent to 24 g TDF/2000 kcal and 12% SWWB (6% TDF) is equivalent to 32 g TDF/ 2000 kcal. Similar extrapolations suggest an upper limit to the protective effect of TDF from SWWB of >32 g/2000 kcal in humans.
It has been proposed that decreased exposure of mammary epithelium to endogenous estrogens may explain the protective effects of dietary fiber (15) . In particular, serum E,S has attracted attention since it is a major circulating storage form of estrogen which can readily be converted to E, and by sulfatases in mammary epithelium (39) . Studies by Woods et al. (16) and Adlercreutz et al. (40) suggested that E,S may be more diet responsive than either E2 or E|. However, despite the fact that, overall, SWWB did lower serum E,S levels compared to alphacel, there were no correlations in this model between serum E,S concentrations and either SWWB intake or mammary tumor yields.
Serum E[ and E2 levels were decreased in the 9% SWWB group compared to all other groups, but the decrease did not achieve statistical significance (Tables IV and V) . The lowest mean levels were exhibited by the 9% SWWB group, and the highest by the 7.5% alphacel group. This is in contrast to the results of Arts et al. (\\) who reported that serum E 2 levels were elevated in rats fed a high wheat bran diet (23%) compared to those fed a low wheat bran diet (1%), and our previous report (10) which also found elevated levels of serum E 2 in animals fed 10% SWWB + 5% cellulose under either high-or low-fat conditions. The reasons for the discrepancies between these and earlier results are unclear but may lie in differences in the source and amount of wheat bran used in the Arts study and in the fact that a mixture of cellulose and SWWB was used in our previous study rather than SWWB alone (9) .
Based on earlier studies (10, 11) , it was expected that urinary estrogen excretion would decline monotonically with respect to increasing dietary SWWB concentrations. As seen in Table VI , this was not the case. However, when the four SWWB groups were pooled, mean total urinary estrogen excretion was significantly depressed when compared to the four pooled alphacel groups. This result indicates that SWWB suppresses the urinary pathway of estrogen excretion compared to cellulose, but not in a non-dose-dependent fashion. Arts et al. (11) reported a significant decrease in urinary E, excretion, compared to rats fed 23% wheat bran versus 1% bran and we found a similar decrease in E) and E 2 levels in rats fed 10% SWWB compared to unsupplemented controls. This result could be explained by the hypothesis that maximum suppression occurred at 9% and that additional SWWB, therefore, had no effect. On the other hand, it is possible that a greater degree of suppression may occur at a dose lower than 9% SWWB-a possibility not tested in this study.
Fecal estrogen excretion among the four SWWB groups exhibited a non-linear increase as SWWB levels in the diet increased (Table VIE) . The lowest levels of all three estrogens were found in the 9% group and the highest in the 18% group, indicating that increased levels of SWWB favored the fecal route of estrogen. A similar pattern was found among the four alphacel groups. Comparison of pooled SWWB groups with pooled alphacel groups revealed a significant elevation in fecal E, (but not E 2 or E 3 ) levels in the SWWB group compared to the alphacel group. Arts et al. (11) found that in rats fed a high-fiber diet, only fecal E 2 was significantly elevated when compared to rats fed low-fiber diets. No change was seen in E\, and E 3 levels were non-significantly elevated in the highfiber compared to the low-fiber group. Again, the reasons for the discrepancy between our results and those of Arts et al. (10) regarding E, and E 2 are unclear but they could be due to differences in fecal estrogen extraction methodology (Arts et al. measured both conjugated and unconjugated fecal estrogens, whereas we measured only unconjugated forms), the source of wheat bran, diet composition or the much wider range in fiber intake used in the Arts study compared to the present study. The increased fecal estrogen excretion in SWWB animals noted in this study is consistent with the fact that wheat bran is more efficient than cellulose at binding and removing estrogens from the colon (10).
Direct comparisons between our results and human studies are difficult because, to our knowledge, no dose-response studies relating fiber intake to estrogen status in humans have yet been reported (Table IX) . Most reports involve comparisons between individuals consuming high-fat/low-fiber diets and those consuming low-fat/high-fiber diets (16, 41, 44, 45) . With some exceptions (45) , decreased serum estrogens and urinary estrogen excretion and increased fecal estrogen excretion were reported in individuals consuming low-fat/high-fiber diets. Only one short-term intervention study by Rose and co-workers (42) distinguished between the type of fiber supplement used. In this report, in which fat was kept constant, wheat bran, but not oat or com bran, supplementation lowered E 2 levels; urinary and fecal estrogen levels were not measured. All of the studies published thus far were compromised by small study populations, by the as yet unresolved problem of which phase (luteal or follicular) in the menstrual cycle provides the best index of estrogen status in premenopausal women, and by the high intra-laboratory variability inherent in estrogen measurements (46, 47) .
In summary, the results of the present study support the conclusion that, at 9% w/w, SWWB inhibits the promotion of NMU-induced mammary tumors by a high-fat diet in comparison to a similar amount of pure cellulose. Implied in this result is the concept that SWWB contains an anti-promoting agent or agents which are absent in cellulose. Moreover, the data also suggest an upper limit to the protective effect (12% SWWB) beyond which no tumor inhibition was seen. The reason for this loss of protection at higher SWWB levels remains to be determined. (It should be reiterated that this study did not address the possibility that dose-related inhibitory effects may occur at SWWB levels <9% SWWB w/w.) Moreover, because estrogen modulation by either fiber source was not consistently correlated with tumor yields, the results cast doubt on, but do not disprove, the validity of the enterohepatic estrogen recirculating hypothesis as a plausible mechanism for dietary fiber's anti-promotional effects (48) . Accordingly, future studies on the anti-promoting effects of SWWB should address (i) the possible effects of SWWB (a) on the relative amounts of bound versus unbound estrogens (49, 50) and (b) on the direction of oxidative metabolism of estrogens [i.e. via the 20HE, or the 160C-OHE, pathways (51)] both of which have been proposed as possible determinants of breast cancer risk; (ii) the anti-promoting role played by various minor constituents of SWWB including phytates (52), protease inhibitors (53) and phytoestrogens (50) ; and (iii) the influence of type and/or amount of dietary fat (9, 40) .
